Gastric cancer patients at high-risk of having synchronous cancer

被引:0
|
作者
Jun Ho Lee
Ja Seong Bae
Keun Won Ryu
Jong Seok Lee
Sook Ryun Park
Chan Gyoo Kim
Myoung Cheorl Kook
Il Ju Choi
Young Woo Kim
Jae-Gahb Park
Jae-Moon Bae
机构
[1] 411-769
[2] 809 Madul-dong
[3] Goyang-si
[4] Gyeonggi-do
[5] Ilsandong-gu
[6] Korea
[7] Research Institute & Hospital National Cancer Center
关键词
Synchronous cancer; Gastric cancer; Colorectal cancer;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
AIM: To identify patients with a high-risk of having a synchronous cancer among gastric cancer patients. METHODS: We retrospectively analyzed the prospective gastric cancer database at the National Cancer Center, Korea from December 2000 to December 2004. The clinicopathological characteristics of patients with synchronous cancers and those of patients without synchronous cancers were compared. Multivariate analysis was performed to identify the risk factors for the presence of a synchronous cancer in gastric cancer patients. RESULTS: 111 of 3291 gastric cancer patients (3.4%) registered in the database had a synchronous cancer. Among these 111 patients, 109 had a single synchronous cancer and 2 patients had two synchronous cancers. The most common form of synchronous cancer was colorectal cancer (42 patients, 37.2%) followed by lung cancer (21 patients, 18.6%). Multivariate analyses revealed that elderly patients with differentiated early gastric cancer have a higher probability of a synchronous cancer. CONCLUSION: Synchronous cancers in gastric cancer patients are not infrequent. The physicians should try to find synchronous cancers in gastric cancer patients, especially in the elderly with a differentiated early gastric cancer.
引用
收藏
页码:2588 / 2592
页数:5
相关论文
共 50 条
  • [31] Robustly federated learning model for identifying high-risk patients with postoperative gastric cancer recurrence
    Feng, Bao
    Shi, Jiangfeng
    Huang, Liebin
    Yang, Zhiqi
    Feng, Shi-Ting
    Li, Jianpeng
    Chen, Qinxian
    Xue, Huimin
    Chen, Xiangguang
    Wan, Cuixia
    Hu, Qinghui
    Cui, Enming
    Chen, Yehang
    Long, Wansheng
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [32] Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High-Risk Gastric/Gastroesophageal Junction Cancer
    Liu, Qin
    Chu, Yanhong
    Shao, Jie
    Qian, Hanqing
    Yang, Ju
    Sha, Huizi
    Cen, Lanqi
    Tian, Manman
    Xu, Qiuping
    Chen, Fangjun
    Yang, Yang
    Wang, Weifeng
    Wang, Kai
    Yu, Lixia
    Wei, Jia
    Liu, Baorui
    ADVANCED SCIENCE, 2023, 10 (01)
  • [33] Are "high-risk" patients with differentiated thyroid cancer "healthy patients"?
    Riemann, B.
    Schober, O.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (05): : 179 - 180
  • [34] Imaging and evaluation of patients with high-risk prostate cancer
    Bjurlin, Marc A.
    Rosenkrantz, Andrew B.
    Beltran, Luis S.
    Raad, Roy A.
    Taneja, Samir S.
    NATURE REVIEWS UROLOGY, 2015, 12 (11) : 617 - 628
  • [35] Medical screening referred to high-risk patients for cancer
    Queisser, W
    ONKOLOGIE, 1995, 18 : 14 - 16
  • [36] Performance of BCRAT in high-risk patients with breast cancer
    Gail, Mitchell H.
    LANCET ONCOLOGY, 2019, 20 (06): : E285 - E285
  • [37] Immuno-Interception for Patients with High-Risk Cancer
    Umar, Asad
    Loomans-Kropp, Holli A.
    CANCER PREVENTION RESEARCH, 2020, 13 (06) : 493 - 495
  • [38] High-Risk Pancreatic Cancer Patients and Quality of Life
    Han, S.
    Kheder, J.
    Kaufman, D.
    Bocelli, L.
    Wachholtz, A.
    Wassef, W.
    PANCREAS, 2014, 43 (08) : 1363 - 1363
  • [39] LONIDAMINE IN HIGH-RISK BREAST-CANCER PATIENTS
    POSSINGER, K
    WAGNER, H
    KOVACS, S
    FLATH, B
    CLASSEN, S
    WILMANNS, W
    SEMINARS IN ONCOLOGY, 1991, 18 (02) : 58 - 61
  • [40] Breast Cancer Treatment in High-Risk Elderly Patients
    Bano, Razia
    Khan, Iqbal Amina
    Zaidi, Akif Abbas
    Zaidi, Asif Syed Adil
    Khan, Huma Majeed
    Chaudhary, Muhammad Zulqarnain
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 32 - 32